16-79594284-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005360.5(MAF):c.*176A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.362 in 649,808 control chromosomes in the GnomAD database, including 43,906 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.34 ( 9012 hom., cov: 31)
Exomes 𝑓: 0.37 ( 34894 hom. )
Consequence
MAF
NM_005360.5 3_prime_UTR
NM_005360.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.01
Publications
11 publications found
Genes affected
MAF (HGNC:6776): (MAF bZIP transcription factor) The protein encoded by this gene is a DNA-binding, leucine zipper-containing transcription factor that acts as a homodimer or as a heterodimer. Depending on the binding site and binding partner, the encoded protein can be a transcriptional activator or repressor. This protein plays a role in the regulation of several cellular processes, including embryonic lens fiber cell development, increased T-cell susceptibility to apoptosis, and chondrocyte terminal differentiation. Defects in this gene are a cause of juvenile-onset pulverulent cataract as well as congenital cerulean cataract 4 (CCA4). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
MAF Gene-Disease associations (from GenCC):
- Ayme-Gripp syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- cataract 21 multiple typesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics
- cataract - microcornea syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- cerulean cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pulverulent cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Fine-Lubinsky syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 16-79594284-T-C is Benign according to our data. Variant chr16-79594284-T-C is described in ClinVar as [Benign]. Clinvar id is 1263394.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.424 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAF | ENST00000326043.5 | c.*176A>G | 3_prime_UTR_variant | Exon 2 of 2 | 1 | NM_005360.5 | ENSP00000327048.4 | |||
MAF | ENST00000569649.1 | c.1118+4501A>G | intron_variant | Intron 1 of 1 | 5 | ENSP00000455097.1 | ||||
MAF | ENST00000393350.1 | c.*4497A>G | downstream_gene_variant | 6 | ENSP00000377019.1 |
Frequencies
GnomAD3 genomes AF: 0.338 AC: 51326AN: 151898Hom.: 9004 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
51326
AN:
151898
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.369 AC: 183616AN: 497794Hom.: 34894 Cov.: 6 AF XY: 0.367 AC XY: 97202AN XY: 264544 show subpopulations
GnomAD4 exome
AF:
AC:
183616
AN:
497794
Hom.:
Cov.:
6
AF XY:
AC XY:
97202
AN XY:
264544
show subpopulations
African (AFR)
AF:
AC:
3311
AN:
13690
American (AMR)
AF:
AC:
7779
AN:
25296
Ashkenazi Jewish (ASJ)
AF:
AC:
6187
AN:
15498
East Asian (EAS)
AF:
AC:
13155
AN:
30292
South Asian (SAS)
AF:
AC:
16017
AN:
48708
European-Finnish (FIN)
AF:
AC:
10912
AN:
27614
Middle Eastern (MID)
AF:
AC:
855
AN:
2086
European-Non Finnish (NFE)
AF:
AC:
115328
AN:
307108
Other (OTH)
AF:
AC:
10072
AN:
27502
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
5709
11419
17128
22838
28547
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.338 AC: 51354AN: 152014Hom.: 9012 Cov.: 31 AF XY: 0.342 AC XY: 25374AN XY: 74278 show subpopulations
GnomAD4 genome
AF:
AC:
51354
AN:
152014
Hom.:
Cov.:
31
AF XY:
AC XY:
25374
AN XY:
74278
show subpopulations
African (AFR)
AF:
AC:
10405
AN:
41468
American (AMR)
AF:
AC:
5303
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
1342
AN:
3466
East Asian (EAS)
AF:
AC:
2272
AN:
5174
South Asian (SAS)
AF:
AC:
1546
AN:
4798
European-Finnish (FIN)
AF:
AC:
4193
AN:
10540
Middle Eastern (MID)
AF:
AC:
108
AN:
294
European-Non Finnish (NFE)
AF:
AC:
25189
AN:
67968
Other (OTH)
AF:
AC:
728
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1709
3418
5127
6836
8545
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1161
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.